Tag Archives: Cardinal Health

April, 2017

November, 2016

  • 28 November

    Cardinal Health to Acquire Lymphoseek from Navidea for up to $310 Million

    DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals (NYSE MKT: NAVB) today announced that it has entered into a definitive asset purchase agreement with Cardinal Health (NYSE: CAH). Pursuant to the purchase agreement, Cardinal Health will purchase Navidea’s Lymphoseek® product for lymphatic mapping, lymph node biopsy and the diagnosis of metastatic spread to lymph …

December, 2015

June, 2015

  • 8 June

    Cardinal Health to Acquire Generics Distributor Harvard Drug Group

    Dublin, Ohio-based Cardinal Health recently announced its plans to buy generic drug distributor, The Harvard Drug Group (THDG), for $1.115 billion. Cardinal Health said that it plans to acquire THDG, a distributor of generic pharmaceuticals, over-the-counter medications and related products to retail, institutional and alternate care customers, currently owned by …

May, 2015

March, 2015